â– LECTURE OVERVIEW: Lithium carbonate is a highly effective mood stabilizer utilized for bipolar disorder, but it carries a narrow therapeutic index.
â– PHARMACOLOGICAL KINETICS & RENAL FILTERS:
1. Narrow Window: The safe therapeutic index for lithium is narrow: 0.6 to 1.2 mEq/L, with toxic manifestations developing above 1.5 mEq/L.
2. Renal Clearance: Lithium is not metabolized; it is excreted 100% unchanged by the kidneys, handled similarly to sodium.
3. Proximal tubule reabsorption: It is freely filtered by the glomerulus, and approximately 80% is reabsorbed in the proximal convoluted tubule (PCT) alongside sodium.
4. Toxicity Triggers: Any state that reduces glomerular filtration rate or increases proximal sodium and water reabsorption will cause a dangerous accumulation of serum lithium, precipitating toxic levels.
â– BIOCHEMICAL MECHANISMS:
At the molecular level, enzyme kinetics govern reaction rates. Competitive inhibitors raise apparent Michaelis constants without changing maximum speed, whereas noncompetitive inhibitors decrease maximum speed directly.
â– CRITICAL CARE MANAGEMENT PROTOCOL:
Continuous cardiopulmonary and metabolic monitoring is paramount during acute decompensation. Maintain strict control over fluid ratios and oxygenation parameters.
[HY-BOARD-1090]
🌟 Dynamic Clinical Key:
Toxicity triggers include dehydration, low-sodium diets, and three classic drug classes: NSAIDs (which block renal prostaglandins to restrict GFR), Thiazide Diuretics (which deplete sodium, driving compensatory PCT reabsorption), and ACE Inhibitors/ARBs. Toxicity presents with severe coarse tremors, ataxia, vomiting, and confusion. Focus on rate-limiting regulatory steps for pharmacological design. Do not delay airway protection and resuscitation maneuvers for low-priority imaging.